Compare BHFAO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHFAO | SNN |
|---|---|---|
| Founded | N/A | 1856 |
| Country | United States | United Kingdom |
| Employees | 1400 | N/A |
| Industry | Life Insurance | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 12.3B |
| IPO Year | 2018 | 2002 |
| Metric | BHFAO | SNN |
|---|---|---|
| Price | $13.91 | $27.78 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 33.3K | ★ 1.7M |
| Earning Date | N/A | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 23.06 | N/A |
| EPS | ★ 2.84 | N/A |
| Revenue | ★ $6,766,000,000.00 | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | ★ $4.89 | $64.97 |
| Revenue Growth | ★ 43.23 | N/A |
| 52 Week Low | $13.75 | $27.23 |
| 52 Week High | $18.18 | $37.64 |
| Indicator | BHFAO | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 35.24 | 38.03 |
| Support Level | $13.78 | N/A |
| Resistance Level | $14.57 | $31.36 |
| Average True Range (ATR) | 0.19 | 0.51 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 13.79 | 21.95 |
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.